Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JANET PAN

NPI
1801056676
CMS profile
354136
Location
FOUNTAIN VALLEY, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$8,105.08

333 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $7,897.42 330
Education $207.66 3

By paying entity

PY2025 · entire year · sorted by reported total

Paying entityAmountRecords
AstraZeneca Pharmaceuticals LP $486.62 20
PFIZER INC. $398.27 19
ABBVIE INC. $384.37 21
Janssen Biotech, Inc. $380.66 16
Bayer Healthcare Pharmaceuticals Inc. $336.61 18
Merck Sharp & Dohme LLC $328.02 11
Novartis Pharmaceuticals Corporation $293.97 12
Celgene Corporation $262.95 15
Eisai Inc. $254.72 12
GlaxoSmithKline, LLC. $224.70 11
Astellas Pharma US Inc $201.31 7
Regeneron Healthcare Solutions, Inc. $197.13 7
PUMA BIOTECHNOLOGY, INC. $193.48 9
Exelixis Inc. $185.81 6
ADC THERAPEUTICS AMERICA, INC. $182.14 4
ARRAY BIOPHARMA INC $180.50 8
SEAGEN INC. $174.94 2
E.R. Squibb & Sons, L.L.C. $164.57 9
Incyte Corporation $162.81 6
Gilead Sciences, Inc. $157.25 6
Takeda Pharmaceuticals U.S.A., Inc. $157.11 6
Karyopharm Therapeutics Inc. $150.91 5
JAZZ PHARMACEUTICALS INC. $138.84 5
GENZYME CORPORATION $135.75 5
Daiichi Sankyo Inc. $130.45 5
Alexion Pharmaceuticals, Inc. $130.14 5
Lilly USA, LLC $125.82 5
Genentech USA, Inc. $124.29 4
PharmaEssentia USA Corporation $121.23 4
SOBI, INC $111.95 4
BeOne Medicines USA, Inc. $110.54 4
Coherus Oncology, Inc. $109.52 4
Sumitomo Pharma America, Inc. $85.12 5
Stemline Therapeutics Inc. $83.49 3
Geron Corporation $80.65 3
Genmab U.S., Inc. $80.37 3
Aveo Pharmaceuticals, Inc. $73.79 2
TerSera Therapeutics LLC $73.48 2
Boehringer Ingelheim Pharmaceuticals, Inc. $71.15 3
TAIHO ONCOLOGY, INC. $66.71 3
Iovance Biotherapeutics, Inc. $63.17 3
Legend Biotech USA Inc. $60.32 2
Pharmacosmos Therapeutics Inc. $55.73 3
SERVIER PHARMACEUTICALS LLC $53.70 2
Apellis Pharmaceuticals, Inc. $49.43 2
Caris MPI, Inc. $42.41 2
EMD Serono, Inc. $42.41 1
Rigel Pharmaceuticals, Inc. $41.34 2
BeiGene USA, Inc. $40.24 2
RECORDATI_RARE_DISEASES_INC. $36.90 2
GE HEALTHCARE $36.83 1
KYOWA KIRIN, INC. $35.94 2
Amgen Inc. $32.72 1
Chiesi USA, Inc. $32.24 2
Blueprint Medicines Corporation $30.97 1
Agios Pharmaceuticals, Inc. $29.68 1
SpringWorks Therapeutics, Inc. $28.95 1
Syndax Pharmaceuticals, Inc. $28.84 1
Fennec Pharmaceuticals, Inc. $21.15 1
SHORLA ONCOLOGY INC. $15.12 1
Ipsen Biopharmaceuticals, Inc $14.85 1

Page 6 of 7; records 251–300 of 333 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JANET PAN

NPI 1801056676 · CMS profile ID 354136

FOUNTAIN VALLEY, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 6 of 7; records 251–300 of 333 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1801056676?year=2025&recipient=provider&page=6#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JANET PAN, NPI 1801056676, CMS profile ID 354136. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 6 of 7; records 251–300 of 333 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1801056676?year=2025&recipient=provider&page=6#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). JANET PAN, NPI 1801056676, CMS profile ID 354136. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 6 of 7; records 251–300 of 333 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1801056676?year=2025&recipient=provider&page=6#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
JANET PAN, NPI 1801056676, CMS profile ID 354136, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 6 of 7; records 251–300 of 333 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1801056676?year=2025&recipient=provider&page=6#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

333 matching records · $8,105.08 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 333 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 251–300 of 333.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
PFIZER INC. $34.0104/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228922625 CMS
Janssen Biotech, Inc. $39.2704/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174604049 CMS
Karyopharm Therapeutics Inc. $24.1403/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1246646423 CMS
PFIZER INC. $18.3603/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228929877 CMS
PUMA BIOTECHNOLOGY, INC. $20.3403/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251746889 CMS
SOBI, INC $21.7203/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240275156 CMS
ABBVIE INC. $23.8203/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203445018 CMS
ABBVIE INC. $0.8503/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203445025 CMS
Lilly USA, LLC $26.1603/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186674911 CMS
Celgene Corporation $12.0103/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184815557 CMS
Lilly USA, LLC $23.0703/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186719985 CMS
Syndax Pharmaceuticals, Inc. $28.8403/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238994004 CMS
Bayer Healthcare Pharmaceuticals Inc. $16.7103/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1225682588 CMS
SpringWorks Therapeutics, Inc. $28.9503/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1232167125 CMS
Merck Sharp & Dohme LLC $23.0103/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238276857 CMS
Celgene Corporation $27.6903/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184815553 CMS
Legend Biotech USA Inc. $30.7803/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1236482694 CMS
AstraZeneca Pharmaceuticals LP $34.9703/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1207289668 CMS
Pharmacosmos Therapeutics Inc. $18.4903/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1250729715 CMS
SHORLA ONCOLOGY INC. $15.1203/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1242558708 CMS
Ipsen Biopharmaceuticals, Inc $14.8503/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1208838085 CMS
Merck Sharp & Dohme LLC $34.3503/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238058929 CMS
Karyopharm Therapeutics Inc. $31.0203/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1246646427 CMS
Sumitomo Pharma America, Inc. $15.1403/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1176701527 CMS
Alexion Pharmaceuticals, Inc. $33.3503/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202979434 CMS
ARRAY BIOPHARMA INC $27.0202/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228889160 CMS
Bayer Healthcare Pharmaceuticals Inc. $14.0302/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1225682596 CMS
Novartis Pharmaceuticals Corporation $23.5802/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200676990 CMS
Celgene Corporation $21.2102/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184815543 CMS
Chiesi USA, Inc. $17.0802/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1242164645 CMS
Incyte Corporation $25.1402/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226053633 CMS
Novartis Pharmaceuticals Corporation $32.7402/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200676986 CMS
Genentech USA, Inc. $33.8002/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1211521125 CMS
Lilly USA, LLC $27.2402/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186719983 CMS
E.R. Squibb & Sons, L.L.C. $14.6502/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184815519 CMS
Janssen Biotech, Inc. $25.6302/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174606561 CMS
SOBI, INC $22.5602/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240275165 CMS
JAZZ PHARMACEUTICALS INC. $25.2802/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234328769 CMS
Bayer Healthcare Pharmaceuticals Inc. $32.6102/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1225682584 CMS
Bayer Healthcare Pharmaceuticals Inc. $0.7802/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1225682586 CMS
Janssen Biotech, Inc. $21.9502/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174605952 CMS
Celgene Corporation $30.6502/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184815535 CMS
Celgene Corporation $2.5002/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184815537 CMS
GlaxoSmithKline, LLC. $19.7702/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190416951 CMS
Pharmacosmos Therapeutics Inc. $17.5802/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1250729713 CMS
Daiichi Sankyo Inc. $27.1202/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1197050387 CMS
PFIZER INC. $27.4602/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228888899 CMS
AstraZeneca Pharmaceuticals LP $27.4002/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206257776 CMS
Bayer Healthcare Pharmaceuticals Inc. $24.9702/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1225682582 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $24.4502/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223033012 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $5,304.61 322
PY2020 $5,339.64 303
PY2021 $6,218.12 325
PY2022 $6,396.31 346
PY2023 $6,939.00 351
PY2024 $7,888.97 348
PY2025 $8,105.08 333

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $96,505.50 3
PY2024 Principal investigator $13,150.00 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

3 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $14,535.50 11/20/2025 Non-covered Recipient Entity
Los Angeles Cancer Network
A Phase 3, Two-Stage, Randomized, Multicenter, Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Subjects with Relapsed or Refractory Multiple Myeloma (RRMM) No dispute reported 06/30/2026 1235996173
Principal investigator 1 Celgene Corporation $55,585.00 06/25/2025 Non-covered Recipient Entity
Los Angeles Cancer Network
A Phase 3, Two-Stage, Randomized, Multicenter, Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Subjects with Relapsed or Refractory Multiple Myeloma (RRMM) No dispute reported 06/30/2026 1222306877
Principal investigator 1 Celgene Corporation $26,385.00 04/23/2025 Non-covered Recipient Entity
Los Angeles Cancer Network
A Phase 3, Two-Stage, Randomized, Multicenter, Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Subjects with Relapsed or Refractory Multiple Myeloma (RRMM) No dispute reported 06/30/2026 1222306937